TEVA-RASAGILINE DIN 02418436
Status: Marketed
Holder: TEVA CANADA LIMITED
Molecule: RASAGILINE (RASAGILINE MESYLATE)
Available to quote
Health Canada record
| Active ingredient(s) | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N04BD02 RASAGILINE |
| Original market date | 30-May-2016 |
| Current status date | 30-May-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RASAGILINE (RASAGILINE MESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02514532 | AG-RASAGILINE | ANGITA PHARMA INC. | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02514540 | AG-RASAGILINE | ANGITA PHARMA INC. | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02404680 | APO-RASAGILINE | APOTEX INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02404699 | APO-RASAGILINE | APOTEX INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02489139 | ASN-RASAGILINE | ASCEND LABORATORIES LTD | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02489120 | ASN-RASAGILINE | ASCEND LABORATORIES LTD | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02284642 | AZILECT | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02284650 | AZILECT | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02491982 | JAMP RASAGILINE | JAMP PHARMA CORPORATION | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02491974 | JAMP RASAGILINE | JAMP PHARMA CORPORATION | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02533723 | MINT-RASAGILINE | MINT PHARMACEUTICALS INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02533731 | MINT-RASAGILINE | MINT PHARMACEUTICALS INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02418444 | TEVA-RASAGILINE | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 18491 | 2016-09-19 | Supplement to a New Drug Submission (SNDS) | UPDATE TO THE PRODUCT MONOGRAPH TO MATCH THE INNOVATOR'S PRODUCT MONOGRAPH |
| 15968 | 2014-08-18 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |